Re: [trust-el] meeting minutes aug 18 2016

[Peter Alterman <palterman@safe-biopharma.org>]

apologies. I misread my schedule (again).

happening too often lately.

sigh

------------------------------------------------------------

Peter Alterman, Ph.D.

Chief Operating Officer
SAFE-BioPharma Association

cell: 301-943-7452

On Thu, Aug 18, 2016 at 12:24 PM, Barbir, Abbie <BarbirA@aetna.com> wrote:

Meeting was quorum (see roster on tc website)

 

1.       Andrew gave status on comment review

2.       All comments have been addressed

3.       Section 8 need to be developed and will be done by end of august

4.       Tc need to provide feedback on all section including 8 by end of august

5.       Andrew to ask Chet for next steps

6.       All previous meeting minutes approved

7.       Meeting adjourned

 

This e-mail may contain confidential or privileged information. If you think you have received this e-mail in error, please advise the sender by reply e-mail and then delete this e-mail immediately. Thank you. Aetna